We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.46 | -0.93% | 49.00 | 42.19 | 50.80 | 49.595 | 48.97 | 49.48 | 1,113,911 | 05:00:11 |
PARIS, April 29, 2016 /PRNewswire/ -- Sanofi, a global and diversified healthcare leader, reports results for the first quarter of 2016. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on the Group's Q1 results and guidance for the rest of the year.
Watch video interview and read transcript:
http://eurobusinessmedia.com/ceo-direct/sanofi/q1-2016-results-interview-with-cfo-jerome-contamine?utm_source=ceo-direct&utm_medium=wire
Topics covered in the interview include:
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Copyright 2016 PR Newswire
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions